These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25307441)

  • 21. Hepatitis C treatment in drug users: perception versus evidence.
    Sylvestre D
    Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):129-30. PubMed ID: 16394792
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of hepatitis C viral infections in substance abusers.
    Robaeys G; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):55-67. PubMed ID: 15832589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting.
    Senn O; Seidenberg A; Rosemann T
    Addiction; 2009 Dec; 104(12):2033-8. PubMed ID: 19922570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone.
    Sylvestre DL; Clements BJ
    Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):741-7. PubMed ID: 17700258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is hepatitis C important for drug addicts?].
    Aavitsland P
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1623. PubMed ID: 19721475
    [No Abstract]   [Full Text] [Related]  

  • 26. [Short-time hepatitis C treatment and drug abuse].
    Kristensen Ø; Rysstad O; Gallefoss F
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2498; author reply 2499. PubMed ID: 19997144
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C.
    Marco A; Esteban JI; Solé C; da Silva A; Ortiz J; Roget M; Sarriera C; Teixidó N; Guerrero RA; Caylà JA
    J Hepatol; 2013 Jul; 59(1):45-51. PubMed ID: 23523577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C.
    Manolakopoulos S; Deutsch MJ; Anagnostou O; Karatapanis S; Tiniakou E; Papatheodoridis GV; Georgiou E; Manesis E; Tzourmakliotis D; Archimandritis AJ
    Liver Int; 2010 Nov; 30(10):1454-60. PubMed ID: 20846344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scale-up of hepatitis C treatment in prisons is key to national elimination.
    Papaluca T; Hellard ME; Thompson AJV; Lloyd AR
    Med J Aust; 2019 May; 210(9):391-393.e1. PubMed ID: 30968417
    [No Abstract]   [Full Text] [Related]  

  • 30. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
    Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of chronic hepatitis C within a heroine-assisted treatment program].
    Deibler P; Haasen C; Reimer J
    Dtsch Med Wochenschr; 2006 Dec; 131(50):2835-7. PubMed ID: 17160765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy.
    Schäfer A; Wittchen HU; Backmund M; Soyka M; Gölz J; Siegert J; Schäfer M; Tretter F; Kraus MR
    Addiction; 2009 Apr; 104(4):630-40. PubMed ID: 19335661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
    N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. People with Hepatitis C Who Inject Drugs - Underserved, Not Undeserving.
    Dore GJ; Trooskin S
    N Engl J Med; 2020 Aug; 383(7):608-611. PubMed ID: 32786185
    [No Abstract]   [Full Text] [Related]  

  • 36. Treating intravenous drug users with hepatitis C infection: an opportunity in some settings.
    Chong VH; Jamaludin AZ; Jacob AP; Jalihal A
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1121. PubMed ID: 16957520
    [No Abstract]   [Full Text] [Related]  

  • 37. The politics of place(ment): problematising the provision of hepatitis C treatment within opiate substitution clinics.
    Rance J; Newland J; Hopwood M; Treloar C
    Soc Sci Med; 2012 Jan; 74(2):245-53. PubMed ID: 22133583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
    J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Gaps in Hepatitis C Care of People Who Use Drugs].
    Bruggmann P
    Praxis (Bern 1994); 2017; 106(7):359-363. PubMed ID: 28357908
    [No Abstract]   [Full Text] [Related]  

  • 40. A French prospective observational study of the treatment of chronic hepatitis C in drug abusers.
    Chossegros P; Mélin P; Hézode C; Bourlière M; Pol S; Fhima A; Filoche B; Trépo C; Couzigou P; Ouzan D; Gagnon A
    Gastroenterol Clin Biol; 2008 Oct; 32(10):850-7. PubMed ID: 18805662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.